ストックスクリーナーアプリを入手
38.33
2.28%
0.8774
Indivior Pharmaceuticals Inc (INDV) 最新ニュース
Indivior Pharmaceuticals Inc (INDV) Stock Up 5.1% but GF Value S - GuruFocus
Net margin % of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Quick ratio of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Diluted net income available to common stockholders of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
After tax other income/expense of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Non-controlling/minority interest of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Book value per share of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Operating income of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Diluted earnings per share (diluted EPS) of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – LSX:A42086 - TradingView
Cash per share of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
ETFs Investing in Indivior Pharmaceuticals, Inc. Stocks - TradingView
EBITDA margin % of Indivior Pharmaceuticals, Inc. – LSX:A42086 - TradingView
Zacks.com featured highlights include Indivior, ReNew Energy, Lifetime, NetScout and TEEKAY - The Globe and Mail
Indivior Pharmaceuticals Drops 6.3% Amid Sector-Wide Selling - AlphaStreet
Indivior Pharmaceuticals (NASDAQ:INDV) Passes Minervini Trend Template and High Growth Momentum Screen - ChartMill
Herantis reports positive FDA feedback and finalizes Phase 2a study design for HER-096 - GlobeNewswire Inc.
AGIO Halts Tebapivat Development in Myelodysplastic Syndromes - TradingView
INDV Stock Chart | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
Top Hemab Therapeutics (COAG) Competitors 2026 - MarketBeat
What to Know About This Fund's $74.8 Million Indivior Sale - The Globe and Mail
Madison Avenue Partners Buys Large Stake in Indivior - HarianBasis.co
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200% - The Globe and Mail
Indivior Pharmaceuticals, Inc. Balance Sheet – DUS:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – DUS:E7P - TradingView
Indivior Pharmaceuticals Inc. (INDV) upgraded to strong buy: Here's what you should know - MSN
Assessing Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After A Strong Multi‑Month Share Price Run - Sahm
Bears are losing control over Indivior Pharmaceuticals Inc. (INDV), here's why it's a 'buy' now - MSN
AGIO's Pyrukynd Gets Approval for Thalassemia in Europe - TradingView
Free cash flow of Indivior Pharmaceuticals, Inc. – GETTEX:E7P - TradingView
Equity in earnings of Indivior Pharmaceuticals, Inc. – GETTEX:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – GETTEX:E7P - TradingView
Does Indivior Pharmaceuticals Inc. (INDV) have the potential to rally 32.48% as Wall Street analysts expect? - MSN
Does Indivior Pharmaceuticals Inc. (INDV) Have the Potential to Rally 32.48% as Wall Street Analysts Expect? - Yahoo Finance
Indivior launches $175M accelerated share buyback - MSN
Indivior (INDV) Shows Benefits of Sublocade for Opioid Use Disor - GuruFocus
Debt to assets ratio of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Net margin % of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Price to cash flow ratio of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Preferred dividends of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Revenue Breakdown – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Income Statement – MUN:E7P - TradingView
Book value per share of Indivior Pharmaceuticals, Inc. – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Earnings and Revenue – MUN:E7P - TradingView
Indivior Pharmaceuticals, Inc. Balance Sheet – MUN:E7P - TradingView
Monthly addiction shot tied to fewer relapses, hospital visits - Stock Titan
The Bull Case For Indivior Pharmaceuticals (INDV) Could Change Following Upgraded Outlook And $175M BuybackLearn Why - Yahoo Finance
New Studies Show Adherence to Monthly Injectable - GlobeNewswire
Indivior Pharmaceuticals Inc. (INDV) is a great choice for 'trend' investors, here's why - MSN
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study - TradingView
INDV News | INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) - ChartMill
Indivior Pharmaceuticals Inc. (INDV) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Indivior Pharmaceuticals Inc. (INDV) Q1 earnings and revenues beat estimates - MSN
Indivior Pharmaceuticals, Inc.Common Stock (Nasdaq:INDV) Stock Quote - The Chronicle-Journal
Indivior Eliminates Chief Scientific Officer Role, Realigns Leadership - The Globe and Mail
2.32%
1.05%
大文字化:
|
ボリューム (24 時間):